What are RMD's business segments?

ResMed Inc. (RMD) reports revenue by product line and geographic region in its 10-K segment disclosures. The composition lists on this page show the most recent breakdown; the expanded table view shows the multi-year transposed history.

Which segment generates the most revenue for RMD?

ResMed Inc.'s largest reported segment is Sleep And Respiratory, at $4.10 billion in revenue for fiscal year 2024 (ended June 30, 2024). It sits at the top of the composition list on this page. Segment mix can shift materially year over year, especially after acquisitions, divestitures, or new-product launches — the expand-modal view shows the full trajectory.

How current is RMD's segment data?

ResMed Inc. (RMD)'s segment breakdown on this page is from its most recent annual filing, fiscal year 2024 (ended June 30, 2024). Segment disclosures are reported annually in the 10-K and refresh within 48 hours of each filing.

RMD

ResMed Inc.

NYSE·Medical, Devices · Healthcare

$195.80$2.81−1.41%

Pre-market·$195.51−0.15%

Market cap$28.40B·Market closed·Jul 21 8:00 PM UTC

Frequently Asked Questions About RMD

What are RMD's business segments?: ResMed Inc. (RMD) reports revenue by product line and geographic region in its 10-K segment disclosures. The composition lists on this page show the most recent breakdown; the expanded table view shows the multi-year transposed history.
Which segment generates the most revenue for RMD?: ResMed Inc.'s largest reported segment is Sleep And Respiratory, at $4.10 billion in revenue for fiscal year 2024 (ended June 30, 2024). It sits at the top of the composition list on this page. Segment mix can shift materially year over year, especially after acquisitions, divestitures, or new-product launches — the expand-modal view shows the full trajectory.
How current is RMD's segment data?: ResMed Inc. (RMD)'s segment breakdown on this page is from its most recent annual filing, fiscal year 2024 (ended June 30, 2024). Segment disclosures are reported annually in the 10-K and refresh within 48 hours of each filing.

RMD

ResMed Inc.

NYSE·Medical, Devices · Healthcare

$195.80$2.81−1.41%

Pre-market·$195.51−0.15%

Market cap$28.40B·Market closed·Jul 21 8:00 PM UTC

By Product

Latest period2024

Segment	Revenue	Share	YoY Growth %
Sleep And Respiratory	$4.10B	87.5%	+10.1%
Software As Service	$584.13M	12.5%	+17.3%

By Geography

Latest period2024

Segment	Revenue	Share	YoY Growth %
U [S]	$2.98B	63.6%	—
Global	$1.71B	36.4%	—

Frequently Asked Questions About RMD

What are RMD's business segments?: ResMed Inc. (RMD) reports revenue by product line and geographic region in its 10-K segment disclosures. The composition lists on this page show the most recent breakdown; the expanded table view shows the multi-year transposed history.
Which segment generates the most revenue for RMD?: ResMed Inc.'s largest reported segment is Sleep And Respiratory, at $4.10 billion in revenue for fiscal year 2024 (ended June 30, 2024). It sits at the top of the composition list on this page. Segment mix can shift materially year over year, especially after acquisitions, divestitures, or new-product launches — the expand-modal view shows the full trajectory.
How current is RMD's segment data?: ResMed Inc. (RMD)'s segment breakdown on this page is from its most recent annual filing, fiscal year 2024 (ended June 30, 2024). Segment disclosures are reported annually in the 10-K and refresh within 48 hours of each filing.